CRIS Current Research Information System

GRAMANTIERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.173
EU - Europa 1.708
AS - Asia 580
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 9
Totale 4.588
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.166
IT - Italia 391
GB - Regno Unito 376
SE - Svezia 251
DE - Germania 191
SG - Singapore 189
CN - Cina 186
IN - India 106
IE - Irlanda 85
CH - Svizzera 77
RU - Federazione Russa 65
FR - Francia 63
UA - Ucraina 58
VN - Vietnam 48
BG - Bulgaria 41
TG - Togo 40
ZA - Sudafrica 32
EE - Estonia 28
FI - Finlandia 25
JO - Giordania 21
EU - Europa 15
CI - Costa d'Avorio 13
BE - Belgio 9
HR - Croazia 9
NL - Olanda 8
MK - Macedonia 7
CA - Canada 6
EC - Ecuador 6
NG - Nigeria 6
IL - Israele 5
PL - Polonia 5
DZ - Algeria 4
RO - Romania 4
SC - Seychelles 4
AM - Armenia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
LB - Libano 3
PK - Pakistan 3
AT - Austria 2
BR - Brasile 2
DK - Danimarca 2
HK - Hong Kong 2
ID - Indonesia 2
JP - Giappone 2
KZ - Kazakistan 2
MD - Moldavia 2
SI - Slovenia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CU - Cuba 1
ES - Italia 1
IR - Iran 1
KE - Kenya 1
KR - Corea 1
LK - Sri Lanka 1
MY - Malesia 1
PE - Perù 1
TH - Thailandia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.588
Salva come PNG Salva come JPEG
Città #
Southend 349
Fairfield 302
Chandler 214
Ashburn 188
Woodbridge 159
Singapore 151
Houston 141
Wilmington 129
Seattle 125
Bologna 118
Princeton 88
Dublin 85
Ann Arbor 79
Cambridge 79
Bern 75
Sofia 41
Lomé 40
Dong Ket 35
Jacksonville 34
Westminster 34
Padova 32
Nanjing 29
Santa Clara 29
Berlin 23
Helsinki 22
Amman 21
Beijing 20
Milan 20
Saint Petersburg 19
Jinan 18
New York 18
Hebei 17
San Diego 17
Florence 15
Turin 15
Boardman 14
Abidjan 13
Zhengzhou 13
Los Angeles 12
Nanchang 11
Des Moines 10
Jiaxing 10
Pune 10
Bremen 9
Brussels 9
Shenyang 9
Bühl 8
Dearborn 8
Falls Church 8
Forlì 8
Haikou 8
Medford 8
Mülheim 8
Norwalk 8
Changsha 7
Abeokuta 6
Chicago 6
Quito 6
Skopje 6
Amsterdam 5
Holon 5
Mountain View 5
Tianjin 5
Toronto 5
Verona 5
Guangzhou 4
Medolla 4
Olalla 4
Philadelphia 4
Reggio Nell'emilia 4
Rome 4
Taizhou 4
Treviso 4
Bari 3
Boydton 3
Bucharest 3
Fuzhou 3
London 3
L’Aquila 3
Mahé 3
Munich 3
Ningbo 3
Paris 3
Peshawar 3
Phoenix 3
Prineville 3
Redmond 3
Russi 3
San Lazzaro di Savena 3
Serio 3
Taiyuan 3
Washington 3
Almaty 2
Atlanta 2
Beverwijk 2
Bolzano 2
Brno 2
Busto Arsizio 2
Capua 2
Casalecchio di Reno 2
Totale 3.131
Salva come PNG Salva come JPEG
Nome #
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 196
LncRNAs as novel players in hepatocellular carcinoma recurrence 140
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 135
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 133
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 129
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 129
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 128
Oncogenic role of miR-483-3p at the IGF2/483 locus. 124
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 120
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 117
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 115
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 114
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 113
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 112
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 108
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. 106
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 105
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas 102
Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. 101
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 101
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. 99
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma 99
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. 98
MicroRNAs in Animal Models of HCC 97
Improving accuracy in the diagnosis of small HCC (< 20 mm) on cirrhosis by a combined CT-MRI Ultrasound navigation system. Preliminary report of a work in progress. 95
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 95
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 93
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA 92
TP53/MicroRNA interplay in hepatocellular carcinoma 90
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 86
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. 79
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 79
null 77
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 76
Efficacy of superselective TACE in treatment of HCC 72
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. 71
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 71
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions 71
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 70
Notch3 intracellular domain accumulates in HepG2 cell line. 70
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 69
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma 65
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 62
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 60
MiR-122 targets serpinB3 and is involved in sorafenib resistance in hepatocellular carcinoma 55
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma 42
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas 39
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research 36
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 35
Animal models of hepatocellular carcinoma prevention 34
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 33
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 32
miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature 29
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 25
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma 17
Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver 13
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing? 10
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 9
Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma 5
Totale 4.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020897 0 0 7 53 99 115 137 151 154 83 50 48
2020/2021558 109 42 16 15 11 38 43 40 75 47 24 98
2021/2022976 55 44 60 86 74 47 19 96 36 84 253 122
2022/20231.084 99 121 62 123 65 93 21 57 192 28 76 147
2023/2024411 32 70 19 37 55 79 13 20 19 30 13 24
2024/2025357 87 222 48 0 0 0 0 0 0 0 0 0
Totale 4.778